Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Pannifer

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Current Pharmaceutical Design|June 2, 2012
Using fragment-based technologies to target protein-protein interactionsJustin F Bower, Andrew Pannifer
Journal of the American Chemical Society|January 12, 2013
Structural insights into a unique inhibitor binding pocket in kinesin spindle proteinVenkatasubramanian Ulaganathan, Sandeep K Talapatra, Oliver Rath, et al.
Acta Crystallographica. Section D, Biological Crystallography|September 4, 2013
Analysis of the human cofilin 1 structure reveals conformational changes required for actin bindingMarta Klejnot, Mads Gabrielsen, Jenifer Cameron, et al.
SLAS Discovery : Advancing Life Sciences R & D|March 18, 2017
In Vitro Assay Development and HTS of Small-Molecule Human ABAD/17β-HSD10 Inhibitors as Therapeutics in Alzheimer's DiseaseLaura Aitken, Gemma Baillie, Andrew Pannifer, et al.
Cell Communication and Signaling : CCS|October 8, 2014
A novel small-molecule MRCK inhibitor blocks cancer cell invasionMathieu Unbekandt, Daniel R Croft, Diane Crighton, et al.
Bioorganic & Medicinal Chemistry Letters|September 20, 2011
Fragment based discovery of a novel and selective PI3 kinase inhibitorSamantha J Hughes, David S Millan, Iain C Kilty, et al.
Bioorganic & Medicinal Chemistry Letters|July 4, 2012
Design and synthesis of a novel pyrrolidinyl pyrido pyrimidinone derivative as a potent inhibitor of PI3Kα and mTORPhuong T Le, Hengmiao Cheng, Sacha Ninkovic, et al.
Chemmedchem|November 2, 2019
Synthesis and Structure-Activity Relationships of N-(4-Benzamidino)-Oxazolidinones: Potent and Selective Inhibitors of Kallikrein-Related Peptidase 6Elena De Vita, Niels Smits, Helma van den Hurk, et al.
Bioorganic & Medicinal Chemistry Letters|April 15, 2004
Imidazo[1,2-b]pyridazines: a potent and selective class of cyclin-dependent kinase inhibitorsKate F Byth, Nicola Cooper, Janet D Culshaw, et al.
Bioorganic & Medicinal Chemistry Letters|February 19, 2019
Structure-based design, synthesis and biological evaluation of a novel series of isoquinolone and pyrazolo[4,3-c]pyridine inhibitors of fascin 1 as potential anti-metastatic agentsStuart Francis, Daniel Croft, Alexander W Schüttelkopf, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Current Pharmaceutical Design|June 2, 2012
Using fragment-based technologies to target protein-protein interactionsJustin F Bower, Andrew Pannifer
Journal of the American Chemical Society|January 12, 2013
Structural insights into a unique inhibitor binding pocket in kinesin spindle proteinVenkatasubramanian Ulaganathan, Sandeep K Talapatra, Oliver Rath, et al.
Acta Crystallographica. Section D, Biological Crystallography|September 4, 2013
Analysis of the human cofilin 1 structure reveals conformational changes required for actin bindingMarta Klejnot, Mads Gabrielsen, Jenifer Cameron, et al.
SLAS Discovery : Advancing Life Sciences R & D|March 18, 2017
In Vitro Assay Development and HTS of Small-Molecule Human ABAD/17β-HSD10 Inhibitors as Therapeutics in Alzheimer's DiseaseLaura Aitken, Gemma Baillie, Andrew Pannifer, et al.
Cell Communication and Signaling : CCS|October 8, 2014
A novel small-molecule MRCK inhibitor blocks cancer cell invasionMathieu Unbekandt, Daniel R Croft, Diane Crighton, et al.
Bioorganic & Medicinal Chemistry Letters|September 20, 2011
Fragment based discovery of a novel and selective PI3 kinase inhibitorSamantha J Hughes, David S Millan, Iain C Kilty, et al.
Bioorganic & Medicinal Chemistry Letters|July 4, 2012
Design and synthesis of a novel pyrrolidinyl pyrido pyrimidinone derivative as a potent inhibitor of PI3Kα and mTORPhuong T Le, Hengmiao Cheng, Sacha Ninkovic, et al.
Chemmedchem|November 2, 2019
Synthesis and Structure-Activity Relationships of N-(4-Benzamidino)-Oxazolidinones: Potent and Selective Inhibitors of Kallikrein-Related Peptidase 6Elena De Vita, Niels Smits, Helma van den Hurk, et al.
Bioorganic & Medicinal Chemistry Letters|April 15, 2004
Imidazo[1,2-b]pyridazines: a potent and selective class of cyclin-dependent kinase inhibitorsKate F Byth, Nicola Cooper, Janet D Culshaw, et al.
Bioorganic & Medicinal Chemistry Letters|February 19, 2019
Structure-based design, synthesis and biological evaluation of a novel series of isoquinolone and pyrazolo[4,3-c]pyridine inhibitors of fascin 1 as potential anti-metastatic agentsStuart Francis, Daniel Croft, Alexander W Schüttelkopf, et al.
Pageof 2